amblyopia lazy eye
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All children of 12-18 months old, born after uneventful pregnancy (>36 weeks), registered at one of the participating children*s healthcare centers (CHCs) and with informed consent by the parents/guardians
Exclusion criteria
Exclusion criteria: Prematurity and perinatal birth damage; Congenital syndromes; Psychomotor retardation; Known hereditary defects; Known cardiac disease; Severe comorbidity; Children*s whose parents do not agree to cyclopegia with the use of cyclopentolate 1% eye drops, Refractive error higher than the AAPOS 2003 criteria twofold, Strabismus; Amblyopia; Ptosis; Cataract or other media opacity; Other ophthalmic disease requiring immediate referral.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The occurrence of amblyopia at the final examination, stratified according to visual acuity of the amblyopic eye in the intervention group and in the control group. The final examination will take place at the age of 4, unless children have been referred to an orthoptist and/or ophthalmologist before, for example when amblyopia or strabismus are suspected before the age of 4. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are: - Prevalence of amblyopia at age 1; - Type and severity of refractive error at age 1; - Occurrence of amblyopia at the final examination, stratified according to visual acuity of the amblyopic eye in the children without high refractive error at age 1; - Pre-literacy skills in the intervention and control group at age 4; - Occurrence of strabismus, determined at the final examination in all groups. Other outcome measures: - Electronically measured compliance with spectacles wearing; - The evolution of refractive error between age 1 and 4; - Gender; - Family history for ocular disease; - Ethnicity; - Parental level of education, social economic status and language skill. | — |
Countries
Netherlands